In addition the dermal administration route further reduces the risks of cytotoxicity or systemic toxicity.
The excellent tolerability of the lipid nanoparticles is supported by many available cosmetic dermal products already being
introduced to the market fulfilling the regulatory requirements towards tolerability and nanotoxicity.
Fromthis it appears justified to call the lipid nanoparticles a “nanosave” carrier.